Breaking News, Collaborations & Alliances

Endocyte, ITG Enter Supply Deal

For Lutetium-177 (177Lu) EndolucinBeta to support clinical and commercial supply of 177Lu-PSMA-617, through 2035

Endocyte and ITM Isotopen Technologien München AG (ITM) announced that ITM´s subsidiary, Isotope Technologies Garching GmbH (ITG), and Endocyte have signed a long-term global supply agreement for the highly purified, no-carrier-added Lutetium-177 (177Lu) EndolucinBeta® to support clinical and commercial supply of 177Lu-PSMA-617, through 2035. “We are pleased to secure this long-term strategic partnership to ensure a reliable supply of no-carrier-added Lutetium-177 through commercializatio...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters